Internal Medicine, Medical Oncology · New York, NY
NPI
1104016724
Since 2007
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
1275 York Ave
New York, NY, 10065
Phone (212) 639-2000
Groups this clinician bills Medicare through
Medicare paid, 2024
$37K
358 services
Medicare patients, 2024
174
Average age 73
Drug cost, 2024
$522K
490 prescriptions
Company payments, 2025
$0
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ayca Gucalp was code 99214 (office e&m - established), 186 times for 108 patients. In total Ayca Gucalp billed 358 services in 6 codes, and Medicare paid $37K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-06-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 186 | 108 | $82.93 | $15K |
| 99215 Office E&M - Established | Office | 124 | 83 | $123.86 | $15K |
| 99205 Office E&M - New | Office | 29 | 29 | $162.82 | $4,722 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 12 | 12 | $27.49 | $330 |
By year: 2022 $41K for 422 services; 2023 $39K for 417 services; 2024 $37K for 358 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ayca Gucalp prescribed most often to Medicare patients was Anastrozole, with 235 prescriptions and refills. In total Ayca Gucalp wrote 490 Medicare prescriptions that cost $522K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 235 | 636 | 77 | $5,133 |
| Exemestane Generic | 54 | 130 | 15 | $6,876 |
| Letrozole Generic | 51 | 125 | 17 | $1,259 |
| Kisqali Ribociclib Succinate | 22 | 22 | Under 11 | $384K |
| Tamoxifen Citrate Generic | 21 | 47 | Under 11 | $662 |
| Aromasin Exemestane | 12 | 17 | Under 11 | $18K |
Brand drugs: 84 claims; generic drugs: 406 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ayca Gucalp $0 (- in general payments such as food, travel and fees) from 1 company.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.